Cargando…

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965

The monocarboxylate transporter 1 (MCT1) is a key element in tumor cell metabolism and inhibition of MCT1 with AZD3965 is undergoing clinical trials. We aimed to investigate nutrient fluxes associated with MCT1 inhibition by AZD3965 to identify possible biomarkers of drug action. We synthesized an (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braga, Marta, Kaliszczak, Maciej, Carroll, Laurence, Schug, Zachary T., Heinzmann, Kathrin, Baxan, Nicoleta, Benito, Adrian, Valbuena, Gabriel N., Stribbling, Stephen, Beckley, Alice, Mackay, Gillian, Mauri, Francesco, Latigo, John, Barnes, Chris, Keun, Hector, Gottlieb, Eyal, Aboagye, Eric O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352845/ https://www.ncbi.nlm.nih.gov/pubmed/32604836 http://dx.doi.org/10.3390/cancers12061703

Ejemplares similares

Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
por: Beloueche-Babari, Mounia, et al.
Publicado: (2020)

In Vivo Anticancer Activity of AZD3965: A Systematic Review
por: Silva, Ana, et al.
Publicado: (2021)

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

In Vitro and In Vivo Characterization of MCT1 Inhibitor AZD3965 Confirms Preclinical Safety Compatible with Breast Cancer Treatment
por: Benyahia, Zohra, et al.
Publicado: (2021)

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965
por: McNeillis, Rosie, et al.
Publicado: (2020)

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
por: Curtis, Nicola J., et al.
Publicado: (2017)

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
por: Noble, Richard A., et al.
Publicado: (2017)

Lactate fluxes mediated by the monocarboxylate transporter-1 are key determinants of the metabolic activity of beige adipocytes
por: Lagarde, Damien, et al.
Publicado: (2020)

The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis
por: Sheng, Xiang-xiang, et al.
Publicado: (2016)

Inward Flux of Lactate(-) through Monocarboxylate Transporters Contributes to Regulatory Volume Increase in Mouse Muscle Fibres
por: Lindinger, Michael I., et al.
Publicado: (2013)

Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using (18)F-ICMT-11 and (18)F-FLT PET
por: Heinzmann, Kathrin, et al.
Publicado: (2018)

Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019)

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography
por: Slade, Rozanna L., et al.
Publicado: (2016)

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth
por: Trousil, Sebastian, et al.
Publicado: (2016)

Monocarboxylate transporters in the brain and in cancer()
por: Pérez-Escuredo, Jhudit, et al.
Publicado: (2016)

AKT activation controls cell survival in response to HDAC6 inhibition
por: Kaliszczak, M, et al.
Publicado: (2016)

Evaluation of apoptosis imaging biomarkers in a genetic model of cell death
por: Vassileva, Vessela, et al.
Publicado: (2019)

Monocarboxylate Transporters: Role and Regulation in Corneal Diabetes
por: Shrestha, Pawan, et al.
Publicado: (2022)

Monocarboxylate transporter expression at the onset of skeletal muscle regeneration
por: Washington, Tyrone A, et al.
Publicado: (2013)

Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
por: Vancamp, Pieter, et al.
Publicado: (2020)

Cooperative transport mechanism of human monocarboxylate transporter 2
por: Zhang, Bo, et al.
Publicado: (2020)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium
por: Ueno, Masaki, et al.
Publicado: (2023)

The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E
por: Namjoshi, Dhananjay R., et al.
Publicado: (2013)

Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells
por: Guo, Chen, et al.
Publicado: (2019)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics
por: Li, Yunqing, et al.
Publicado: (2021)

Monocarboxylate Transporters and Lactate Metabolism in Equine Athletes: A Review
por: Pösö, AR
Publicado: (2002)

Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice
por: Schutkowski, Alexandra, et al.
Publicado: (2014)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors
por: Silva, Eduardo C.A., et al.
Publicado: (2018)

Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
por: Forero-Quintero, Linda S., et al.
Publicado: (2017)

The transport mechanism of monocarboxylate transporter on spinosin in Caco-2 cells
por: Meng, Xiang Le, et al.
Publicado: (2016)

Astrocytes and neurons communicate via a monocarboxylic acid shuttle
por: Roosterman, Dirk, et al.
Publicado: (2020)

Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment
por: van Geest, Ferdy S., et al.
Publicado: (2021)

Visual analysis on the research of monocarboxylate transporters based on CiteSpace
por: Li, Feifei, et al.
Publicado: (2021)

Monocarboxylate Transporters 1 and 4 and MTCO1 in Gastric Cancer
por: Eskuri, Maarit, et al.
Publicado: (2021)

GKRP-dependent modulation of feeding behavior by tanycyte-released monocarboxylates
por: Salgado, Magdiel, et al.
Publicado: (2022)

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
por: Kaliszczak, M, et al.
Publicado: (2013)

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16b756cp9bac8785fd9p31bsln